Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Figure Technology Solutions Inc. Class A Common Stock (FIGR) vs Heron Therapeutics Inc (HRTX) Price & Performance

Figure Technology Solutions Inc. Class A Common StockTrade
Heron Therapeutics IncTrade

Price performance (Past 24H)

Key statistics

Figure Technology Solutions Inc. Class A Common Stock vs Heron Therapeutics Inc — how do they compare? Figure Technology Solutions Inc. Class A Common Stock trades at $28.01 (market cap $6.19B), while Heron Therapeutics Inc trades at $0.37 (market cap $68.01M). The key difference: Figure Technology Solutions Inc. Class A Common Stock is far larger — about 91× Heron Therapeutics Inc's market cap, and Figure Technology Solutions Inc. Class A Common Stock is more actively traded (4,762,342 versus 1,891,941). Which is the better fit depends on your goals — on Pluang, investors hold Figure Technology Solutions Inc. Class A Common Stock for 0 Days and Heron Therapeutics Inc for 35 Days on average.

FIGRHRTX
Market Cap
$6.19B$68.01M
Volume
4,762,3421,891,941
Sector
FinancialsHealth
52-Week High
$73.91$1.49
52-Week Low
$24.91$0.27
Typical Hold Time
0 Days35 Days
Enterprise Value
$6.23B$174.75M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Figure Technology Solutions Inc. Class A Common Stock

No Aura AI signal available yet.

Heron Therapeutics Inc

HRTX trades at $0.39, up 17.58% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7 million but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics, analyst consensus remains strongly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings performance discussions.

The outlook is mixed: strong analyst support and technical momentum suggest potential upside, but persistent losses and high valuation ratios pose significant risks. Investment opportunity hinges on revenue growth translating to profitability, while key risks include execution challenges and competitive pressures in the biotechnology sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FIGR
100% Buy0% Sell
Avg holding period · 0 Days
HRTX
8% Buy92% Sell
Avg holding period · 35 Days

About Figure Technology Solutions Inc. Class A Common Stock

Figure Technology Solutions operates a blockchain-native capital marketplace. Its platform supports loan origination, funding, sale, and trading of tokenized assets, along with digital-asset infrastructure and services.

Read more on FIGR →

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX →